The plaintiff, Brenda Honeycutt, works for a financial services company based in Alameda County in California. She had a spinal decompression procedure done with the Coflex interlaminar stabilization device to treat spondylolisthesis, according to a lawsuit filed July 29 in the U.S. District Court for the Central District of California.
Ms. Honeycutt, who was covered under an ERISA health plan, received a letter from Anthem on May 11 saying her claim for surgery with the device was denied.
Anthem’s letter said the denial was on the basis that the Coflex device was “experimental/investigational,” the lawsuit said. The FDA considers Coflex a class 3 medical device, which “usually sustain or support life, are implanted or prevent potential unreasonable risk of illness or injury,” according to court documents filed July 27.
Anthem didn’t immediately respond to a request for comment Aug. 2.This article will be updated if the insurer responds.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
